Imperial College London

MsJessicaPrestt

Faculty of MedicineDepartment of Surgery & Cancer

Director of Development and Delivery, IGHI Education
 
 
 
//

Contact

 

j.prestt

 
 
//

Location

 

Queen Elizabeth and Queen Mary HospitalSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Patel:2016:10.1377/hlthaff.2015.1416,
author = {Patel, H and Wilson, E and Vizzotti, C and Parston, G and Prestt, J and Darzi, A},
doi = {10.1377/hlthaff.2015.1416},
journal = {Health Affairs},
pages = {301--308},
title = {Argentina's successful implementation of a national human papillomavirus vaccination program},
url = {http://dx.doi.org/10.1377/hlthaff.2015.1416},
volume = {35},
year = {2016}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Every year around fourteen million people globally are infected with human papillomavirus (HPV), the sexually transmitted virus that is the cause of most cervical cancers. A number of vaccines have been developed to protect against HPV, but in many countries, HPV vaccination rates have been low compared with rates for other recommended vaccines. Parental concerns, cost, and lack of information and awareness among both health professionals and parents are cited as important barriers to HPV vaccination. In Argentina the HPV vaccine has been provided to all eleven-year-old girls since 2011 as part of a comprehensive national program to prevent cervical cancer. Coverage increased from negligible levels before 2011 to a national average of 87.9 percent for the first dose, 71.6 percent for the second dose, and 52.2 percent for the third dose in 2013. There was a large variance in HPV vaccine coverage across the country’s provinces. This article describes key strategies to overcome barriers to implementation of HPV vaccination and provides recommendations for policy makers.
AU - Patel,H
AU - Wilson,E
AU - Vizzotti,C
AU - Parston,G
AU - Prestt,J
AU - Darzi,A
DO - 10.1377/hlthaff.2015.1416
EP - 308
PY - 2016///
SN - 0278-2715
SP - 301
TI - Argentina's successful implementation of a national human papillomavirus vaccination program
T2 - Health Affairs
UR - http://dx.doi.org/10.1377/hlthaff.2015.1416
UR - http://hdl.handle.net/10044/1/32440
VL - 35
ER -